Omega Healthcare Investors vs Sabra Health Care REIT
OHI and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OHI and SBRA compare
Omega Healthcare Investors is the larger company, worth 2.8 times as much as Sabra Health Care REIT ($14.2B against $5.0B).
On earnings, Omega Healthcare Investors is cheaper: it trades at 17.0× trailing earnings, against 75.9× for Sabra Health Care REIT.
Sabra Health Care REIT grew revenue faster over the last twelve months (17.3% versus 15.0% for Omega Healthcare Investors).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 67.0% compared with 7.6% at Sabra Health Care REIT.
Both pay dividends: Omega Healthcare Investors yields 5.7% and Sabra Health Care REIT 6.1%.
Omega Healthcare Investors scores higher on the StockData Score (12 against 7 for Sabra Health Care REIT), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OHI | SBRA |
|---|---|---|
| Size and price | ||
| Market cap | $14.2B | $5.0B |
| Share price | $46.98 | $19.74 |
| Change, 1 year | 18.8% | 14.6% |
| Change, 5 years | 57.0% | 32.2% |
| Beta (5Y) | 0.27 | 0.48 |
| Employees | 69 | 58 |
| StockData Score | ||
| Total score | 12 (better) | 7 |
| Valuation score | 3 (better) | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 2 | 2 |
| Health score | 0 | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 17.0× (better) | 75.9× |
| P/S | 11.1× | 5.9× (better) |
| P/B | 2.6× | 1.8× (better) |
| EV/EBITDA | 10.0× (better) | 12.5× |
| PEG | 6.71 | – |
| Fair value | $52.14 | $12.68 |
| Margin of safety | 9.9% (better) | −55.7% |
| Growth | ||
| Revenue growth (TTM) | 15.0% | 17.3% (better) |
| Revenue growth, 5Y average | 5.9% (better) | 5.3% |
| Net income growth (TTM) | 82.4% (better) | −64.1% |
| EPS growth (TTM) | 73.1% (better) | −65.8% |
| EPS growth, 5Y average | 22.6% (better) | −0.91% |
| Profitability | ||
| Net margin | 67.0% (better) | 7.6% |
| Return on equity | 16.5% (better) | 2.4% |
| Financial health | ||
| Altman Z-score | 2.81 (better) | 1.25 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 5.7% | 6.1% (better) |
| Payout ratio | 92.6% | 455% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 0.00% (better) | −2.3% |
| Shareholder yield | 5.7% | 6.1% (better) |
| Ownership | ||
| Held by institutions | 81.8% | 102% |
| Held by insiders | 0.19% | 1.9% |
| Insider net buying, 12 months | $1.4M (better) | −$4.5M |
| Short interest, % of float | 5.2% | 7.9% |
Go deeper
- OHI stock overview
- OHI income statement
- OHI valuation and score
- SBRA stock overview
- SBRA income statement
- SBRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.